A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer
Conditions: Hepatocellular Carcinoma (HCC) Interventions: Drug: BAY3630942; Drug: BAY3547922 Sponsors: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Early Detection of Liver Cancer by QUS
Conditions: Hepatocellular Carcinoma; Liver Cancer Interventions: Diagnostic Test: Quantitative Ultrasound; Diagnostic Test: B-mode Ultrasound; Diagnostic Test: Magnetic Resonance Imaging; Diagnostic Test: Liver Biopsy Sponsors: Centre hospitalier de l ' Universit é de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l ' Universit é de Montréal; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Conditions: Hepatocellular Carcinoma; Intrahepatic Cholangiocarcinoma; Cholangiocarcinoma; Primary Liver Cancer; Primary Liver Carcinoma; Hepatic Cancer; Hepatic Carcinoma Interventions: Diagnostic Test: ELUCIDATE Sponsors: City of Hope Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy
Conditions: Lung Cancer; Liver Cancer; Pancreatic Cancer; Renal Cell Carcinoma Interventions: Radiation: SBRT Sponsors: Peking University Third Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Early Detection of Advanced Adenomas and Colorectal Cancer
Conditions: Colorectal Cancer; Colorectal Neoplasms; Colorectal Polyp; Colorectal Adenocarcinoma; Colorectal Disorders; Colorectal Dysplasia; Colorectal Cancer Stage I; Colorectal Cancer Stage II; Colorectal Cancer Stage III; Colorectal Cancer Stage IV; Colorectal Neoplasms Malignant; Colorectal Serrated Adenocarcinoma; Colorectal Adenoma With Severe Dysplasia; Colorectal Adenoma With Mild Dysplasia; Colorectal Adenoma With Moderate Dysplasia; Colorectal Adenoma and Carcinoma 1; Colorectal Adenomatous Polyp; Colorectal Adenocarcinoma Metastatic in the Liver Interventions: Diagnostic Test: DENEB Sponsors: City of Hope Medic...
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Interventions: Drug: Atezolizumab; Drug: Bevacizumab; Radiation: Photon radiotherapy Sponsors: Chang Gung Memorial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Interventions: Drug: INCB099280 Sponsors: Abramson Cancer Center at Penn Medicine; Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort
Conditions: Hepatocellular Carcinoma; Radioembolization Interventions: Other: Simultaneous 18F-Choline PET-MRI Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma; Lenvatinib; PD-1 Inhibitor; Hepatic Arterial Infusion Chemotherapy Interventions: Procedure: Hepatic arterial infusion chemotherapy; Drug: Lenvatinib; Drug: Tislelizumab; Drug: Toripalimab; Drug: Sintilimab; Drug: Camrelizumab Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma
Conditions: Liver Transplantation; Hepatocellular Carcinoma; Alpha-Fetoprotein; Protein Induced by Vitamin K Absence or Antagonist-II Sponsors: Zhejiang University; Shulan (Hangzhou) Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Impact of " No-touch " Technique on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
Conditions: Liver Transplantation; No-touch Technique; Hepatocellular Carcinoma Interventions: Procedure: Liver transplantation with " No-touch " technique Sponsors: Zhejiang University; Shulan (Hangzhou) Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma
Conditions: High Risk of Recurrence Interventions: Drug: Lenvatinib 10 mg Sponsors: Chang Gung Memorial Hospital; Ministry of Health and Welfare, Taiwan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients
Conditions: Hepatocellular Carcinoma Interventions: Other: measure of Glutamine synthetase and BCLFAF1 Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma; Advanced Hepatocellular Carcinoma; Liver Cancer Interventions: Drug: ETN101 Sponsors: Etnova Therapeutics Corp. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Phase 1 Study of ETN101 in Patients With Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma; Advanced Hepatocellular Carcinoma; Liver Cancer Interventions: Drug: ETN101 Sponsors: Etnova Therapeutics Corp. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
